PortfoliosLab logoPortfoliosLab logo
TNGX vs. NLR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

TNGX vs. NLR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tango Therapeutics, Inc. (TNGX) and VanEck Uranium and Nuclear ETF (NLR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TNGX achieves a 206.77% return, which is significantly higher than NLR's -13.99% return.


TNGX

1D
-1.41%
1M
-7.74%
6M
134.11%
YTD
206.77%
1Y
316.23%
3Y*
102.77%
5Y*
22.08%
10Y*
ALL TIME*
18.69%

NLR

1D
-1.41%
1M
-7.05%
6M
-28.16%
YTD
-13.99%
1Y
-2.28%
3Y*
23.67%
5Y*
18.29%
10Y*
11.00%
ALL TIME*
3.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$43.05M$48.38M$60.74M
$60.56M$71.36M$111.26M

TNGX vs. NLR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
TNGX
Tango Therapeutics, Inc.
206.77%186.73%-68.79%36.55%-33.73%-4.37%15.79%
NLR
VanEck Uranium and Nuclear ETF
-13.99%56.50%14.26%36.67%2.29%13.63%11.60%

Correlation

The correlation between TNGX and NLR is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (3Y)
Balances recent behavior with more history.

0.19

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.22

Correlation (All Time)
Calculated using the full available price history since Sep 3, 2020

0.21

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TNGX vs. NLR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TNGX
TNGX Risk / Return Rank: 9898
Overall Rank
TNGX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
TNGX Sortino Ratio Rank: 9797
Sortino Ratio Rank
TNGX Omega Ratio Rank: 9696
Omega Ratio Rank
TNGX Calmar Ratio Rank: 9999
Calmar Ratio Rank
TNGX Martin Ratio Rank: 9999
Martin Ratio Rank

NLR
NLR Risk / Return Rank: 1010
Overall Rank
NLR Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NLR Sortino Ratio Rank: 1111
Sortino Ratio Rank
NLR Omega Ratio Rank: 1111
Omega Ratio Rank
NLR Calmar Ratio Rank: 99
Calmar Ratio Rank
NLR Martin Ratio Rank: 99
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TNGX vs. NLR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tango Therapeutics, Inc. (TNGX) and VanEck Uranium and Nuclear ETF (NLR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TNGXNLRDifference
Sharpe ratioReturn per unit of total volatility

+3.60

Sortino ratioReturn per unit of downside risk

+3.83

Omega ratioGain probability vs. loss probability

1.50

1.02

+0.48

Calmar ratioReturn relative to maximum drawdown

12.06

-0.12

+12.18

Martin ratioReturn relative to average drawdown

29.31

-0.26

+29.57

TNGX vs. NLR - Sharpe Ratio Comparison

The current TNGX Sharpe Ratio is 3.50, which is higher than the NLR Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of TNGX and NLR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TNGX vs. NLR - Drawdown Comparison

The maximum TNGX drawdown since its inception was -93.64%, which is greater than NLR's maximum drawdown of -65.05%. Use the drawdown chart below to compare losses from any high point for TNGX and NLR.


Loading charts...

Drawdown Indicators


TNGXNLRDifference

Max Drawdown

Largest peak-to-trough decline

-93.64%

-65.05%

-28.59%

Max Drawdown (1Y)

Largest decline over 1 year

-29.24%

-37.52%

+8.28%

Max Drawdown (3Y)

Largest decline over 3 years

-91.46%

-37.52%

-53.94%

Max Drawdown (5Y)

Largest decline over 5 years

-93.64%

-37.52%

-56.12%

Max Drawdown (10Y)

Largest decline over 10 years

-37.52%

Current Drawdown

Current decline from peak

-17.39%

-35.01%

+17.62%

Average Drawdown

Average peak-to-trough decline

-47.16%

-35.67%

-11.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.01%

17.42%

-5.41%

Volatility

TNGX vs. NLR - Volatility Comparison

Tango Therapeutics, Inc. (TNGX) has a higher volatility of 18.65% compared to VanEck Uranium and Nuclear ETF (NLR) at 12.90%. This indicates that TNGX's price experiences larger fluctuations and is considered to be riskier than NLR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TNGXNLRDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.65%

12.90%

+5.75%

Volatility (6M)

Calculated over the trailing 6-month period

74.78%

32.42%

+42.36%

Volatility (1Y)

Calculated over the trailing 1-year period

100.91%

43.80%

+57.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

102.52%

30.13%

+72.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.56%

24.58%

+70.98%

Dividends

TNGX vs. NLR - Dividend Comparison

TNGX has not paid dividends to shareholders, while NLR's dividend yield for the trailing twelve months is around 2.96%.


PositionTTM20252024202320222021202020192018201720162015
NLR
VanEck Uranium and Nuclear ETF
2.96%2.55%0.76%4.54%2.02%1.99%2.23%2.21%3.91%4.86%3.62%3.30%
TNGX
Tango Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


TNGX and NLR have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TNGX has higher volatility (18.65%) compared to NLR (12.90%). In terms of maximum drawdown, TNGX dropped -93.64% vs NLR's -65.05%.

TNGX currently has the higher Sharpe Ratio (3.50 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TNGX and NLR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer